Compositions of interleukin and pyrimidine nucleosides

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/20 (2006.01) A61K 31/70 (2006.01)

Patent

CA 2220837

A synergistic antitumor pharmaceutical composition comprising an effective amount of interleukin-12 and a pyrimidine nucleoside derivative as well as a hydrate or solvate thereof that is converted into fluorouracil or its derivative, and a pharmaceutically acceptable carrier.

L'invention porte sur une composition pharmaceutique synergique antitumorale, comprenant un volume efficace d'interleukine-12 et d'un dérivé de nucléoside de pyrimidine ainsi qu'un hydrate ou un solvate de celui-ci, converti en fluoro-uracil ou en un dérivé de ce dernier ainsi qu'un véhicule acceptable du point de vue pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions of interleukin and pyrimidine nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions of interleukin and pyrimidine nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of interleukin and pyrimidine nucleosides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1418245

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.